Dihexa has not been tested in large-scale human clinical trials and does not hold FDA approval for any indication
Injectable healing protocol: 23 mg daily (upper end of range), systemic injection - not into the wound itself - daily until the wound resolves, plus 12 weeks maintenance Topical healing protocol: 2 %4 % in a wound-appropriate vehicle applied 23 times daily to wound margins (never into an open, actively bleeding wound) under clinician supervision Stacking: GHK-Cu pairs exceptionally well with BPC-157 and TB-500 - the so-called GLOW stack - for complex healing cases

Storage Requirements Stability Information Protect from lightProtect from oxidationKeep refrigerated Lyophilized (powder) -20C 24+ months Reconstituted 2-8C ~30 days Research Applications About This Compound Skin and wound healing research studied for effects on collagen synthesis and tissue remodeling Anti-aging research investigated for gene expression effects related to inflammation and cellular aging Hair follicle research studied for stimulating hair growth and reducing follicle miniaturization Compatible with standard bacteriostatic water reconstitution use the peptide reconstitution calculator for exact draw volumes Pairs well with BPC-157 and TB-500 in recovery-focused research protocols For research purposes only
Our work resulted in one receptor agonist, Nle 1 -AngIV and two receptor antagonists, divalinal-AngIV and norleual-AngIV [66-69]
Glutathione injections are used by most individuals for skin whitening, enhanced glowing, and pigmentation reduction
Topical Glutathione Products : Topical glutathione products, like creams, serums, and lotions, are applied directly to the skin